GlobeNewswire by notified

Sella Group launches biometric payment cards in Italy with IDEMIA on IDEX Biometrics TrustedBio solution

Share

Oslo, Norway – 22 November 2022 – IDEX Biometrics ASA announces that Sella Group in Italy has launched biometric payment cards in collaboration with IDEMIA, powered by IDEX Biometrics sensor solution. This launch follows the IDEX Biometrics recent announcement of a major UAE bank launching a full-scale biometric payment card program in the Middle East, indicating a significant market acceleration. 

Sella Group, founded in 1886, is Italy’s largest privately owned and independent banking group with presence in 5 countries. The biometric payment card will initially be offered to selected target segments. Recent launches by established banks point to biometric payment cards being highly value-adding for digital banks and fintechs as well as for more traditional full-service banks, such as Sella Group.

“IDEX Biometrics innovative technology and sensor solutions are bringing seamless payment experiences to more consumers, as cardholders around the globe access limitless contactless payments, secured by the user’s unique fingerprint. IDEX Biometrics is proudly supporting our partner IDEMIA and Sella Group with smarter and more secure card payments that work flawlessly with any payment terminal”, said Catharina Eklof, Chief Commercial Officer of IDEX Biometrics.

For further information contact:
Marianne Bøe, Head of Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186


About IDEX Biometrics

IDEX Biometrics (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal authentication for all.  We help people make payments, prove their identity, gain access to information or unlock devices with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com

TRADEMARK STATEMENT
IDEX, IDEX Biometrics and the IDEX logo are trademarks owned by IDEX Biometrics ASA. All other brands or product names are the property of their respective holders.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Amlan International Adds Sales Manager, Distribution Partner and is Granted New Registration of Calibrin-Z in the Philippines29.11.2022 22:41:20 CET | Press release

CHICAGO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Amlan International, the animal health business of Oil-Dri® Corporation of America, is pleased to announce exciting new developments for their business in the Philippines. Jayson Fernandez joined Amlan as a sales manager for the Philippines in January 2022 and FJ Wegon Animal Health and Nutrition Inc. is now registered to distribute proven biotoxin binder Calibrin®-Z. Registration is pending of additional high-value feed additives, such as patented Varium®, designed for poultry feed efficiency. The Philippines is the fourth-largest poultry producer in Southeast Asia, producing 1.4 million tons of broiler meat in 2020, and the third-largest swine producer in Asia, producing 1.5 million tons of pork meat. However, these production achievements have not been without challenges. The poultry industry is still recovering from COVID-19 disruptions, and swine repopulation efforts are continuing after African swine fever outbreaks. “As producers in the

Conagen develops high-purity non-GMO sulforaphane by bioconversion29.11.2022 21:23:38 CET | Press release

Commercial production is underway for 2023. Bedford, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen’s bioconversion methods enable the production of sustainable products from many naturally occurring compounds regardless of rarity or small quantities occurring in nature. “As a supplement product, Conagen’s high-purity sulforaphane is appealing to consumers as the levels found in raw vegetables are too low to realize many of its promising health benefits,” said Casey Lippmeier, Ph.D., senior vice president of innovation. “We’re looking forward to expanding the nutritional market by commercializing sulforaphane in 2023.” Sulforaphane has been associated with supporting health benefits against cancer, diabetes, digestion, a

Yara’s employee share purchase program and mandatory notification of trades29.11.2022 19:02:00 CET | Press release

Oslo, 29 November 2022: The Foundation for employees’ shares in Yara (“Stiftelsen For Ansattes Aksjer i Yara”) has today purchased a total of 34,000 Yara shares (ticker: YAR, ISIN: NO0010208051) in the market at an average price of NOK 463.9398 per share, as part of Yara’s employee share purchase program in Norway. Permanent Yara employees in Norway can take part in the annual offer to buy Yara shares for a value of either NOK 7,500, NOK 15,000 or NOK 30,000. Based on the three alternatives, Yara employees purchased either 16 Yara shares, 32 Yara shares or 64 Yara shares at NOK 466.40 per share. In total, Yara employees purchased 33,264 Yara shares from the Foundation for employees’ shares in Yara. A total of 605 employees participated in the program. Following these transactions, the Foundation for employees’ shares in Yara owns 748 Yara shares. The share purchases linked to the employee share purchase program by the following Yara Board members are considered as PDMR trades under the

Rovio Entertainment Corporation: Repurchase of own shares on 29 November 202229.11.2022 17:45:00 CET | Press release

Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 29.11.2022 at 18.45 EETRovio Entertainment Corporation - Repurchase of own shares on 29.11.2022Rovio Entertainment CorporationIn the Nasdaq HelsinkiDate29.11.2022Exchange transactionBUYShare trading codeROVIOAmount, shares27148Average price/share, EUR5,942434Total cost, EUR161325,20Rovio now holds a total of 6 382 613 shares including the shares repurchased on 29.11.2022On behalf of Rovio Entertainment CorporationOP Corporate Bank PLC Further information: Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution: Nasdaq Helsinki Ltd Key media www.rovio.com About Rovio: Rovio Entertainment Corporation is a global mobile-first games company that creates, develops and publishes mobile games, which have been downloaded over 5 billion times. Rovio is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainmen